As of 3:59pm ET
| -1.55 / -3.92%|
The 3 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 38.00, with a high estimate of 40.00 and a low estimate of 36.00. The median estimate represents a +0.11% increase from the last price of 37.96.
The current consensus among 3 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.